Platelet-activating factor: a potential mediator of shock. 1987

P Braquet, and M Paubert-Braquet, and P Bessin, and B B Vargaftig
Institut Henri Beaufour, Research Laboratories, Le Plessis Robinson, France.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D010972 Platelet Activating Factor A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. AGEPC,Acetyl Glyceryl Ether Phosphorylcholine,PAF-Acether,Phosphorylcholine, Acetyl Glyceryl Ether,1-Alkyl-2-acetyl-sn-glycerophosphocholine,Platelet Aggregating Factor,Platelet Aggregation Enhancing Factor,Platelet-Activating Substance,Thrombocyte Aggregating Activity,1 Alkyl 2 acetyl sn glycerophosphocholine,Aggregating Factor, Platelet,Factor, Platelet Activating,PAF Acether,Platelet Activating Substance
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012769 Shock A pathological condition manifested by failure to perfuse or oxygenate vital organs. Circulatory Collapse,Circulatory Failure,Hypovolemic Shock,Collapse, Circulatory,Failure, Circulatory,Shock, Hypovolemic
D012772 Shock, Septic Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. Endotoxin Shock,Septic Shock,Shock, Endotoxic,Shock, Toxic,Toxic Shock,Toxic Shock Syndrome,Endotoxin Shocks,Shock Syndrome, Toxic,Shock, Endotoxin,Shocks, Endotoxin,Toxic Shock Syndromes

Related Publications

P Braquet, and M Paubert-Braquet, and P Bessin, and B B Vargaftig
February 1985, European journal of pharmacology,
P Braquet, and M Paubert-Braquet, and P Bessin, and B B Vargaftig
January 1995, Surgery today,
P Braquet, and M Paubert-Braquet, and P Bessin, and B B Vargaftig
July 1995, Journal of internal medicine,
P Braquet, and M Paubert-Braquet, and P Bessin, and B B Vargaftig
November 2022, BioFactors (Oxford, England),
P Braquet, and M Paubert-Braquet, and P Bessin, and B B Vargaftig
January 1985, Advances in prostaglandin, thromboxane, and leukotriene research,
P Braquet, and M Paubert-Braquet, and P Bessin, and B B Vargaftig
January 1988, Progress in biochemical pharmacology,
P Braquet, and M Paubert-Braquet, and P Bessin, and B B Vargaftig
January 1990, Cerebrovascular and brain metabolism reviews,
P Braquet, and M Paubert-Braquet, and P Bessin, and B B Vargaftig
November 1988, Hospital practice (Office ed.),
P Braquet, and M Paubert-Braquet, and P Bessin, and B B Vargaftig
November 2003, The Journal of physiology,
P Braquet, and M Paubert-Braquet, and P Bessin, and B B Vargaftig
May 1988, The Journal of allergy and clinical immunology,
Copied contents to your clipboard!